Table 2 Prevalence (%) of active headache disorder by type and geographical area (estimated in this study and, for migraine and TTH, in GBD2019)

Global

100

183

52.0 (48.9–55.4)

35 (32.3–37.7)

244

14.0 (12.9–15.2)

15.2 (13.2–17.4)

110

26.0 (22.7–29.5)

26.8 (23.5–30.1)

59

4.6 (3.8–5.4)

CEECA

5.3

14

53.6 (41.8–65.2)

41.8 (38.6–44.9)

18

16.6 (12.6–21.3)

15.6 (13.6–17.9)

15

31.1 (22.8–39.2)

35.2 (31.3–39.0)

8

5.2 (3.3–7.2)

HI

14.7

88

51.9 (47.5–56.6)

43.4 (40.2–46.5)

117

13.7 (12.3–15.5)

17.2 (15.1–19.9)

41

30.4 (24.4–36.5)

36.4 (32.4–40.4)

24

3.4 (2.9–4.1)

LAC

7.4

24

55.0 (44.9–65.4)

36.7 (33.8–39.7)

33

17.0 (12.9–22.0)

16.3 (14.1–19.1)

11

26.8 (16.1–39.8)

27.9 (24.4–31.4)

6

6.4 (5.0–7.5)

SEEAO

27.6

10

38.7 (20.4–56.5)

37.3 (34.3–40.4)

16

9.0 (6.0–13.1)

17.5 (15.1–20.2)

8

11.1 (3.5–19.5)

27.7 (24.2–31.2)

5

2.8

NAME

7.7

20

60.5 (50.9–68.5)

35.4 (32.3–38.6)

30

11.8 (9.4–14.4)

16.7 (14.4–19.4)

19

20.5 (14.4–27.8)

25.7 (22.1–29.4)

7

4.9 (3.0–6.9)

SA

23.4

7

53.2 (29.0–74.1)

35.6 (32.7–38.6)

8

22.2 (16.1–27.8)

15.5 (13.4–17.9)

5

33.1 (20.3–42.9)

27.4 (24.1–31.0)

4

6.9

SSA

14.0

19

43.8 (32.4–55.6)

27.4 (24.6–30.2)

21

12.4 (9.1–16.8)

11.3 (9.5–13.3)

10

16.6 (12.4–21.0)

21.0 (17.9–24.4)

4

6.7